{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:52:10Z","timestamp":1775724730074,"version":"3.50.1"},"reference-count":36,"publisher":"Informa UK Limited","issue":"13","funder":[{"DOI":"10.13039\/100011404","name":"Indivior UK, Ltd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011404","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.1080\/14656566.2016.1209486","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T17:42:07Z","timestamp":1467654127000},"page":"1727-1731","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Buprenorphine dosing choices in specific populations: review of expert opinion"],"prefix":"10.1080","volume":"17","author":[{"given":"Icro","family":"Maremmani","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Santa Chiara University Hospital, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Rolland","sequence":"additional","affiliation":[{"name":"Departments of Addiction Medicine and Pharmacology, INSERM, University Hospital of Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Somaini","sequence":"additional","affiliation":[{"name":"Addiction Treatment Centre, Biella, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Roncero","sequence":"additional","affiliation":[{"name":"Addiction and Dual Diagnosis Unit, Department of Psychiatry, Vall d\u2019Hebron Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[{"name":"Director at Centre for Interdisciplinary Addiction Research, University Medical Centre Hamburg-Eppendorf, Martini Strasse, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat","family":"Wright","sequence":"additional","affiliation":[{"name":"Spectrum Community Health CIC, Wakefield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Littlewood","sequence":"additional","affiliation":[{"name":"Applied Strategic, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Krajci","sequence":"additional","affiliation":[{"name":"Division of Mental Health and Addiction, Department of Substance Use Disorder Treatment, Oslo University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Alho","sequence":"additional","affiliation":[{"name":"HA, Clinicum, University of Helsinki and University Hospital, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"D\u2019Agnone","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Human Sciences, Institute of Brain Behaviour and Mental Health, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Simon","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie Clinique, Sainte Marguerite Hospital, Marseille, France"},{"name":"Department of Clinical Pharmacology, Medical School of Marseilles, Marseille, France"},{"name":"Aix Marseille University, INSERM, UMR 912 IRD, SESSTIM, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.976"},{"key":"CIT0002","unstructured":"Bell J. Medications in recovery: re-orientating drug dependence treatment Appendix C \u2013 opioid substitution treatment and its effectiveness: review of the evidence. National Treatment Agency for Substance Misuse. 2012 Jul 1\u201313."},{"key":"CIT0003","volume-title":"characteristics: Subutex 0.4mg sublingual tablets","author":"Summary of product","year":"2015"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1159\/000259614"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01232.x"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1027-0"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-0942-4"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164"},{"key":"CIT0009","volume-title":"SERAF RAPPORT 2\/2015 En aldrende LAR-populasjon?","author":"Waal H"},{"key":"CIT0010","volume-title":"Medicaments Psychotropes","author":"INSERM","year":"2012"},{"key":"CIT0011","volume-title":"Progetto STAR (Strenghtening treatment access and retention for heroin addiction in Italia)","author":"FedDerSerD","year":"2013"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.03.007"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.20882\/adicciones.704"},{"key":"CIT0014","unstructured":"D\u2019Agnone O. Analysis of OST dosing from provider database. Personal communication. 2013."},{"key":"CIT0015","unstructured":"Lintzeris N, Clark N, Winstock A, et al. National clinical guidelines and procedures for the use of buprenorphine in the maintenance treatment of opioid dependence [Internet]. 2006 [cited 2016 Feb 26]. Available from: http:\/\/www.nationaldrugstrategy.gov.au\/internet\/drugstrategy\/publishing.nsf\/content\/9011C92D2F6E1FC5CA2575B4001353B6\/$File\/bupren.pdf"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1012613"},{"key":"CIT0017","first-page":"7","volume":"7","author":"Doran C","year":"2005","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.12.009"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2011.00153.x"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.10.017"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.596974"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2165\/11633230-000000000-00000"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011117.pub2"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.642758"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300251"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03577.x"},{"issue":"1","key":"CIT0027","volume":"11","author":"Courty P","year":"2009","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.025"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.10.014"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02843.x"},{"key":"CIT0031","first-page":"IS26","volume":"152","author":"Fhima A","year":"2001","journal-title":"Ann M\u00e9d Interne"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2014.09.2805"},{"key":"CIT0033","first-page":"B9","volume":"151","author":"De Ducla M","year":"2000","journal-title":"Ann M\u00e9d Interne"},{"key":"CIT0034","volume-title":"characteristics: methadone hydrochloride DTF 1mg\/1ml oral solution","author":"Summary of product","year":"2014"},{"key":"CIT0035","first-page":"CD009879","volume":"6","author":"Ferri M","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480200058024"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2016.1209486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T12:50:19Z","timestamp":1597495819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2016.1209486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,9,1]]}},"alternative-id":["10.1080\/14656566.2016.1209486"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2016.1209486","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}